Evidence map›Paper›PMID 41132760›Full record

ArticleFrontiers in pediatrics2025

Follow-up study on the long-term effectiveness of the home-visiting program "ProKind": study protocol for a randomized controlled trial.

Sören Kliem, Malte Sandner, Tilman Brand, Sebastian Fischer, Anna Lohmann, Marie Lisanne Schepan, Gabriella Conti, Dirk Baier

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sören KliemDepartment of Social Welfare, Ernst-Abbe-Hochschule Jena, Jena, Germany.
Malte SandnerDepartment of Business Administration, Georg Simon Ohm University of Applied Sciences Nuremberg, Nuremberg, Germany.
Tilman BrandDepartment of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology (LG), Bremen, Germany.
Sebastian FischerDepartment of Social Welfare, Ernst-Abbe-Hochschule Jena, Jena, Germany.
Anna LohmannDepartment of Social Welfare, Ernst-Abbe-Hochschule Jena, Jena, Germany.
Marie Lisanne SchepanDepartment of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology (LG), Bremen, Germany.
Gabriella ContiDepartment of Economics, University College London, London, United Kingdom.
Dirk BaierInstitute of Delinquency and Crime Prevention, Zurich University of Applied Sciences, Zürich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Nurse-Family Partnership (NFP) is an evidence-based home visiting program shown to improve maternal and child outcomes. Pro Kind is the first German adaptation of NFP, implemented between 2006 and 2012. While earlier evaluations demonstrated short- and medium-term benefits, no European trial has yet assessed long-term effects into adolescence. Objectives: This study protocol outlines the third phase of the Pro Kind randomized controlled trial (RCT), designed to evaluate the program's effectiveness 14-16 years post-intervention. Primary aims are to assess adolescent and maternal outcomes related to mental health, parenting, risk behaviors, and life satisfaction, as well as potential long-term economic effects. Methods: The original RCT enrolled 755 pregnant women with psychosocial risk factors, randomly assigned to an intervention (

Indexed as

follow-upnurse family partnership programrandomized controlled trial (RCT)study protocolsustained nurse home visiting programs (SNHVs)

Identifiers

PMID41132760
PMCPMC12540121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.